{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:55:43Z","timestamp":1758398143927},"reference-count":94,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2020,12,22]]},"abstract":"<jats:sec>\n<jats:title \/>\n<jats:p>With respect to the unknowns of pathophysiology of Alzheimer\u2019s Disease (AD)-, and\nParkinson\u2019s Disease (PD)-like neurodegenerative disorders, natural product research is still one of\nthe valid tools in order to provide alternative and\/or better treatment options. At one hand, various\nextracts of herbals provide a combination of actions targeting multiple receptors, on the other hand,\nthe discovery of active natural products (i.e., secondary metabolites) generally offers alternative\nchemical structures either ready to be employed in clinical studies or available to be utilized as\nimportant scaffolds for the design of novel agents. Regarding the importance of certain enzymes\n(e.g. cholinesterase and monoamine oxidase B), for the treatment of AD and PD, we have surveyed\nthe natural product research within this area in the last decade. Particularly novel natural agents\ndiscovered within this period, concomitant to novel biological activities displayed for known\nnatural products, are harmonized within the present study.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207323666200127145246","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T14:34:55Z","timestamp":1580135695000},"page":"862-876","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Recent Look into Natural Products that have Potential to Inhibit Cholinesterases and Monoamine Oxidase B: Update for 2010-2019"],"prefix":"10.2174","volume":"23","author":[{"given":"Hayrettin O.","family":"Gulcan","sequence":"first","affiliation":[{"name":"Division of Pharmaceutical Chemistry, Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, TR. North Cyprus, via Mersin 10, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkay E.","family":"Orhan","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara 06300, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.metabol.2016.05.018","volume":"65","author":"Procaccini C.","year":"2016","unstructured":"Procaccini C.; Santopaolo M.; Faicchia D.; Colamatteo A.; Formisano L.; de Candia P.; Galgani M.; De Rosa V.; Matarese G.; Role of metabolism in neurodegenerative disorders. Metabolism 2016,65(9),1376-1390","journal-title":"Metabolism"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"Zecca L.","year":"2004","unstructured":"Zecca L.; Youdim M.B.; Riederer P.; Connor J.R.; Crichton R.R.; Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004,5(11),863-873","journal-title":"Nat Rev Neurosci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1016\/j.bmc.2014.08.016","volume":"22","author":"Gulcan H.O.","year":"2014","unstructured":"Gulcan H.O.; Unlu S.; Esiringu I.; Ercetin T.; Sahin Y.; Oz D.; Sahin M.F.; Design, synthesis and biological evaluation of novel 6H-benzo[c]chromen-6-one, and 7,8,9,10-tetrahydro-benzo[c]chromen-6-one derivatives as potential cholinesterase inhibitors. Bioorg Med Chem 2014,22(19),5141-5154","journal-title":"Bioorg Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.2174\/1568026616666160204121832","volume":"16","author":"Orhan I.E.","year":"2016","unstructured":"Orhan I.E.; Senol F.S.; Designing multi-targeted therapeutics for the treatment of Alzheimer\u2019s disease. Curr Top Med Chem 2016,16(17),1889-1896","journal-title":"Curr Top Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tips.2008.10.005","volume":"30","author":"Schapira A.H.","year":"2009","unstructured":"Schapira A.H.; Neurobiology and treatment of Parkinson\u2019s disease. Trends Pharmacol Sci 2009,30(1),41-47","journal-title":"Trends Pharmacol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.psych.48.1.649","volume":"48","author":"Everitt B.J.","year":"1997","unstructured":"Everitt B.J.; Robbins T.W.; Central cholinergic systems and cognition. Annu Rev Psychol 1997,48(1),649-684","journal-title":"Annu Rev Psychol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijpsycho.2009.01.011","volume":"73","author":"Fotiou D.F.","year":"2009","unstructured":"Fotiou D.F.; Stergiou V.; Tsiptsios D.; Lithari C.; Nakou M.; Karlovasitou A.; Cholinergic deficiency in Alzheimer\u2019s and Parkinson\u2019s disease: evaluation with pupillometry. Int J Psychophysiol 2009,73(2),143-149","journal-title":"Int J Psychophysiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","volume":"50","author":"Giacobini E.","year":"2004","unstructured":"Giacobini E.; Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 2004,50(4),433-440","journal-title":"Pharmacol Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"Leeson P.D.","year":"2007","unstructured":"Leeson P.D.; Springthorpe B.; The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 2007,6(11),881-890","journal-title":"Nat Rev Drug Discov"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/gps.1402","volume":"21","author":"Takeda A.","year":"2006","unstructured":"Takeda A.; Loveman E.; Clegg A.; Kirby J.; Picot J.; Payne E.; Green C.; A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer\u2019s disease. Int J Geriatr Psychiatry 2006,21(1),17-28","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-004-2132-z","volume":"180","author":"Van Dam D.","year":"2005","unstructured":"Van Dam D.; Abramowski D.; Staufenbiel M.; De Deyn P.P.; Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacology (Berl) 2005,180(1),177-190","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","volume":"13","author":"Mushtaq G.","year":"2014","unstructured":"Mushtaq G.; Greig N.H.; Khan J.A.; Kamal M.A.; Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus. CNS  2014,13(8),1432-1439","journal-title":"CNS"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.14712\/18059694.2018.95","volume":"47","author":"Pato\u010dka J.","year":"2004","unstructured":"Pato\u010dka J.; Ku\u010da K.; Jun D.; Acetylcholinesterase and butyrylcholinesterase--important enzymes of human body. Acta Med (Hradec Kralove) 2004,47(4),215-228","journal-title":"Acta Med (Hradec Kralove)"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4088\/JCP.v61n1101","volume":"61","author":"Stahl S.M.","year":"2000","unstructured":"Stahl S.M.; The new cholinesterase inhibitors for Alzheimer\u2019s disease, Part 2: illustrating their mechanisms of action. J Clin Psychiatry 2000,61(11),813-814","journal-title":"J Clin Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","volume":"221","author":"Bohnen N.I.","year":"2011","unstructured":"Bohnen N.I.; Albin R.L.; The cholinergic system and Parkinson disease. Behav Brain Res 2011,221(2),564-573","journal-title":"Behav Brain Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"Connolly B.S.","year":"2014","unstructured":"Connolly B.S.; Lang A.E.; Pharmacological treatment of Parkinson disease: a review. JAMA 2014,311(16),1670-1683","journal-title":"JAMA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"Youdim M.B.","year":"2006","unstructured":"Youdim M.B.; Edmondson D.; Tipton K.F.; The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 2006,7(4),295-309","journal-title":"Nat Rev Neurosci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","volume":"147","author":"Youdim M.B.","year":"2006","unstructured":"Youdim M.B.; Bakhle Y.S.; Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness. Br J Pharmacol 2006,147(S1),S287-S296","journal-title":"Br J Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1248\/cpb.40.2155","volume":"40","author":"Ikeda K.","year":"1992","unstructured":"Ikeda K.; Murata K.; Kobayashi M.; Noda K.; Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem Pharm Bull (Tokyo) 1992,40(8),2155-2158","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=20","first-page":"25","volume":"51","author":"Shih J.C.","year":"1999","unstructured":"Shih J.C.; Chen K.; Ridd M.J.; Role of MAO A and B in neurotransmitter metabolism and behavior. Pol J Pharmacol 1999,51(1),25-29","journal-title":"Pol J Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fphar.2016.00340","volume":"7","author":"Finberg J.P.","year":"2016","unstructured":"Finberg J.P.; Rabey J.M.; Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol 2016,7,340","journal-title":"Front Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"14033","DOI":"10.1074\/jbc.272.22.14033","volume":"272","author":"Tsugeno Y.","year":"1997","unstructured":"Tsugeno Y.; Ito A.; A key amino acid responsible for substrate selectivity of monoamine oxidase A and B. J Biol Chem 1997,272(22),14033-14036","journal-title":"J Biol Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1021\/tx010073b","volume":"14","author":"Kalgutkar A.S.","year":"2001","unstructured":"Kalgutkar A.S.; Dalvie D.K.; Castagnoli N.; Taylor T.J.; Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors. Chem Res Toxicol 2001,14(9),1139-1162","journal-title":"Chem Res Toxicol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1478-811X-11-34","volume":"11","author":"Meiser J.","year":"2013","unstructured":"Meiser J.; Weindl D.; Hiller K.; Complexity of dopamine metabolism. Cell Commun Signal 2013,11(1),34","journal-title":"Cell Commun Signal"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/bies.10067","volume":"24","author":"Betarbet R.","year":"2002","unstructured":"Betarbet R.; Sherer T.B.; Greenamyre J.T.; Animal models of Parkinson\u2019s disease. BioEssays 2002,24(4),308-318","journal-title":"BioEssays"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1517\/13543784.2014.897694","volume":"23","author":"D\u00e9zsi L.","year":"2014","unstructured":"D\u00e9zsi L.; V\u00e9csei L.; Safinamide for the treatment of Parkinson\u2019s disease. Expert Opin Investig Drugs 2014,23(5),729-742","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=27","first-page":"174S","volume":"27","author":"Fernandez H. H.","year":"2007","unstructured":"Fernandez H. H.; Chen J. J.;  Monoamine oxidase\u2010B inhibition in the treatment of Parkinson's diseasePharmacotherapy 2007,27(12P2),174S-185S","journal-title":"Monoamine oxidase\u2010B inhibition in the treatment of Parkinson's diseasePharmacotherapy"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/13543784.15.1.1","volume":"15","author":"Martinez A.","year":"2006","unstructured":"Martinez A.; Castro A.; Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer\u2019s disease. Expert Opin Investig Drugs 2006,15(1),1-12","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/13543776.2014.982535","volume":"25","author":"Carradori S.","year":"2015","unstructured":"Carradori S.; Petzer J.P.; Novel monoamine oxidase inhibitors: a patent review (2012 - 2014). Expert Opin Ther Pat 2015,25(1),91-110","journal-title":"Expert Opin Ther Pat"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nchem.2479","volume":"8","author":"Rodrigues T.","year":"2016","unstructured":"Rodrigues T.; Reker D.; Schneider P.; Schneider G.; Counting on natural products for drug design. Nat Chem 2016,8(6),531-541","journal-title":"Nat Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fnins.2016.00375","volume":"10","author":"Ramsay R.R.","year":"2016","unstructured":"Ramsay R.R.; Majekova M.; Medina M.; Valoti M.; Key targets for multi-target ligands designed to combat neurodegeneration. Front Neurosci 2016,10,375","journal-title":"Front Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2174\/1570180815666180115144608","volume":"15","author":"Norouzbahari M.","year":"2018","unstructured":"Norouzbahari M.; Burgaz E.V.; Ercetin T.; Fallah A.; Foroumadi A.; Firoozpour L.; Gulcan H.O.; Design, synthesis and characterization of novel urolithin derivatives as cholinesterase inhibitor agents. Lett Drug Des Discov 2018,15(11),1131-1140","journal-title":"Lett Drug Des Discov"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.4155\/fmc-2017-0124","volume":"9","author":"Ol\u011fa\u00e7 A.","year":"2017","unstructured":"Ol\u011fa\u00e7 A.; Orhan I.E.; Banoglu E.; The potential role of in silico approaches to identify novel bioactive molecules from natural resources. Future Med Chem 2017,9(14),1665-1686","journal-title":"Future Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/1389201015666141202105105","volume":"16","author":"Gulcan H.O.","year":"2015","unstructured":"Gulcan H.O.; Orhan I.E.; Sener B.; Chemical and molecular aspects on interactions of galanthamine and its derivatives with cholinesterases. Curr Pharm Biotechnol 2015,16(3),252-258","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.15171\/bi.2014.001","volume":"4","author":"Orhan I.E.","year":"2014","unstructured":"Orhan I.E.; Pharmacognosy: Science of natural products in drug discovery. Bioimpacts 2014,4(3),109-110","journal-title":"Bioimpacts"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/157018006776743215","volume":"3","author":"Orhan G.","year":"2006","unstructured":"Orhan G.; Orhan I.; Sener B.; Recent developments in natural and synthetic drug research for Alzheimer\u2019s disease. Lett Drug Des Discov 2006,3(4),268-274","journal-title":"Lett Drug Des Discov"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.foodchem.2009.03.095","volume":"117","author":"Loizzo M.R.","year":"2009","unstructured":"Loizzo M.R.; Menichini F.; Conforti F.; Tundis R.; Bonesi M.; Saab A.M.; Frega N.G.; Chemical analysis, antioxidant, antiinflammatory and anticholinesterase activities of Origanum ehrenbergii Boiss and Origanum syriacum L. essential oils. Food Chem 2009,117(1),174-180","journal-title":"Food Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.5650\/jos.58.443","volume":"58","author":"Loizzo M.R.","year":"2009","unstructured":"Loizzo M.R.; Menichini F.; Tundis R.; Bonesi M.; Conforti F.; Nadjafi F.; Statti G.A.; Frega N.G.; Menichini F.; In vitro biological activity of Salvia leriifolia benth essential oil relevant to the treatment of Alzheimer\u2019s disease. J Oleo Sci 2009,58(8),443-446","journal-title":"J Oleo Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.fct.2009.03.004","volume":"47","author":"Orhan I.","year":"2009","unstructured":"Orhan I.; Senol F.S.; G\u00fclpinar A.R.; Kartal M.; Sekeroglu N.; Deveci M.; Kan Y.; Sener B.; Acetylcholinesterase inhibitory and antioxidant properties of Cyclotrichium niveum, Thymus praecox subsp. caucasicus var. caucasicus, Echinacea purpurea and E. pallida. Food Chem Toxicol 2009,47(6),1304-1310","journal-title":"Food Chem Toxicol"},{"key":"ref=40","first-page":"260","volume":"4","author":"Shahwar D.","year":"2010","unstructured":"Shahwar D.; Rehman S.U.; Raza M.A.; Acetylcholinesterase inhibition potential and antioxidant activities of ferulic acid isolated from Impatiens bicolor Linn. J Med Plants Res 2010,4(3),260-266","journal-title":"J Med Plants Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.foodchem.2010.10.050","volume":"126","author":"Ozt\u00fcrk M.","year":"2011","unstructured":"Ozt\u00fcrk M.; Kolak U.; Topcu G.; Oksuz S.; Choudhary M.I.; Antioxidant and anticholinesterase active constituents from Micromeria cilicica by radical-scavenging activity-guided fractionation. Food Chem 2011,126(1),31-38","journal-title":"Food Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.phytochem.2009.10.018","volume":"71","author":"Halldorsdottir E.S.","year":"2010","unstructured":"Halldorsdottir E.S.; Jaroszewski J.W.; Olafsdottir E.S.; Acetylcholinesterase inhibitory activity of lycopodane-type alkaloids from the Icelandic Lycopodium annotinum ssp. alpestre. Phytochemistry 2010,71(2-3),149-157","journal-title":"Phytochemistry"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.fitote.2010.06.022","volume":"81","author":"Khan I.","year":"2010","unstructured":"Khan I.; Nisar M.; Khan N.; Saeed M.; Nadeem S.; Fazal-ur-Rehman; Ali, F.; Karim, N.; Kaleem, W.A.; Qayum, M.; Ahmad, H.; Khan, I.A. Structural insights to investigate conypododiol as a dual cholinesterase inhibitor from Asparagus adscendens. Fitoterapia 2010,81(8),1020-1025","journal-title":"Fitoterapia"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1345\/aph.1L402","volume":"43","author":"Desilets A.R.","year":"2009","unstructured":"Desilets A.R.; Gickas J.J.; Dunican K.C.; Role of huperzine a in the treatment of Alzheimer\u2019s disease. Ann Pharmacother 2009,43(3),514-518","journal-title":"Ann Pharmacother"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.bmc.2010.01.074","volume":"18","author":"Geissler T.","year":"2010","unstructured":"Geissler T.; Brandt W.; Porzel A.; Schlenzig D.; Kehlen A.; Wessjohann L.; Arnold N.; Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus. Bioorg Med Chem 2010,18(6),2173-2177","journal-title":"Bioorg Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3109\/14756360903389856","volume":"25","author":"Bonesi M.","year":"2010","unstructured":"Bonesi M.; Menichini F.; Tundis R.; Loizzo M.R.; Conforti F.; Passalacqua N.G.; Statti G.A.; Menichini F.; Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents. J Enzyme Inhib Med Chem 2010,25(5),622-628","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.phymed.2009.06.006","volume":"17","author":"Satheeshkumar N.","year":"2010","unstructured":"Satheeshkumar N.; Mukherjee P.K.; Bhadra S.; Saha B.P.; Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. Phytomedicine 2010,17(3-4),292-295","journal-title":"Phytomedicine"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1177\/0960327110391686","volume":"30","author":"Mossa A.T.H.","year":"2011","unstructured":"Mossa A.T.H.; Nawwar G.A.M.; Free radical scavenging and antiacetylcholinesterase activities of Origanum majorana L. essential oil. Hum Exp Toxicol 2011,30(10),1501-1513","journal-title":"Hum Exp Toxicol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.foodchem.2010.12.085","volume":"126","author":"Costa P.","year":"2011","unstructured":"Costa P.; Gon\u00e7alves S.; Andrade P.B.; Valent\u00e3o P.; Romano A.; Inhibitory effect of Lavandula viridis on Fe(2+)-induced lipid peroxidation, antioxidant and anti-cholinesterase properties. Food Chem 2011,126(4),1779-1786","journal-title":"Food Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.fitote.2010.11.003","volume":"82","author":"Bhadra S.","year":"2011","unstructured":"Bhadra S.; Mukherjee P.K.; Kumar N.S.; Bandyopadhyay A.; Anticholinesterase activity of standardized extract of Illicium verum Hook. f. fruits. Fitoterapia 2011,82(3),342-346","journal-title":"Fitoterapia"},{"key":"ref=51","first-page":"248","volume":"5","author":"Lee S.H.","year":"2011","unstructured":"Lee S.H.; Bafna M.R.; Sancheti S.S.; Seo S.Y.; Acetylcholineterase inhibitory and antioxidant properties of Rhododendron yedoense var. poukhanense bark. J Med Plants Res 2011,5(2),248-254","journal-title":"J Med Plants Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.indcrop.2012.01.016","volume":"38","author":"Ustun O.","year":"2012","unstructured":"Ustun O.; Senol F.S.; Kurkcuoglu M.; Orhan I.E.; Kartal M.; Baser K.H.C.; Investigation on chemical composition, anticholinesterase and antioxidant activities of extracts and essential oils of Turkish Pinus species and pycnogenol. Ind Crops Prod 2012,38,115-123","journal-title":"Ind Crops Prod"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.phymed.2012.03.010","volume":"19","author":"Chaiyana W.","year":"2012","unstructured":"Chaiyana W.; Okonogi S.; Inhibition of cholinesterase by essential oil from food plant. Phytomedicine 2012,19(8-9),836-839","journal-title":"Phytomedicine"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/10286020.2013.794417","volume":"15","author":"Ali F.","year":"2013","unstructured":"Ali F.; Khan H.U.; Afzal M.; Samad A.; Khan S.U.; Ali I.; Two new cholinesterase inhibitors asiatoates A and B from Buddleja asiatica. J Asian Nat Prod Res 2013,15(6),631-637","journal-title":"J Asian Nat Prod Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.phymed.2012.12.016","volume":"20","author":"Chaiyana W.","year":"2013","unstructured":"Chaiyana W.; Schripsema J.; Ingkaninan K.; Okonogi S.; 3\u2032-R\/S-hydroxyvoacamine, a potent acetylcholinesterase inhibitor from Tabernaemontana divaricata. Phytomedicine 2013,20(6),543-548","journal-title":"Phytomedicine"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5214\/ans.0972.7531.200203","volume":"20","author":"Ijomone O.M.","year":"2013","unstructured":"Ijomone O.M.; Obi A.U.; Kolaviron, isolated from Garcinia kola, inhibits acetylcholinesterase activities in the hippocampus and striatum of wistar rats. Ann Neurosci 2013,20(2),42-46","journal-title":"Ann Neurosci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/14786419.2012.708660","volume":"27","author":"Zhang X.","year":"2013","unstructured":"Zhang X.; Oh M.; Kim S.; Kim J.; Kim H.; Kim S.; Houghton P.J.; Whang W.; Epimediphine, a novel alkaloid from Epimedium koreanum inhibits acetylcholinesterase. Nat Prod Res 2013,27(12),1067-1074","journal-title":"Nat Prod Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1590\/0001-3765201420130005","volume":"86","author":"Hajimehdipoor H.","year":"2014","unstructured":"Hajimehdipoor H.; Mosaddegh M.; Naghibi F.; Haeri A.; Hamzeloo-Moghadam M.; Natural sesquiterpene lactones as acetylcholinesterase inhibitors. An Acad Bras Cienc 2014,86(2),801-806","journal-title":"An Acad Bras Cienc"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.phytol.2014.09.007","volume":"10","author":"Khan S.","year":"2014","unstructured":"Khan S.; Wang Z.; Wang R.; Zhang L.; Horizontoates A\u2013C: New cholinesterase inhibitors from Cotoneaster horizontalis. Phytochem Lett 2014,10,204-208","journal-title":"Phytochem Lett"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1177\/1934578X1400900423","volume":"9","author":"Koay Y.H.","year":"2014","unstructured":"Koay Y.H.; Basiri A.; Murugaiyah V.; Chan K.L.; Isocorilagin, a cholinesterase inhibitor from Phyllanthus niruri. Nat Prod Commun 2014,9(4),515-517","journal-title":"Nat Prod Commun"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejmech.2014.05.002","volume":"81","author":"Huang G.","year":"2014","unstructured":"Huang G.; Kling B.; Darras F.H.; Heilmann J.; Decker M.; Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine. Eur J Med Chem 2014,81,15-21","journal-title":"Eur J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1016\/j.bmc.2014.06.030","volume":"22","author":"Alza N.P.","year":"2014","unstructured":"Alza N.P.; Richmond V.; Baier C.J.; Freire E.; Baggio R.; Murray A.P.; Synthesis and cholinesterase inhibition of cativic acid derivatives. Bioorg Med Chem 2014,22(15),3838-3849","journal-title":"Bioorg Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.phymed.2014.11.003","volume":"22","author":"Liew S.Y.","year":"2015","unstructured":"Liew S.Y.; Khaw K.Y.; Murugaiyah V.; Looi C.Y.; Wong Y.L.; Mustafa M.R.; Litaudon M.; Awang K.; Natural indole butyrylcholinesterase inhibitors from Nauclea officinalis. Phytomedicine 2015,22(1),45-48","journal-title":"Phytomedicine"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.fct.2017.03.016","volume":"109","author":"Orhan I.E.","year":"2017","unstructured":"Orhan I.E.; Senol F.S.; Shekfeh S.; Skalicka-Wozniak K.; Banoglu E.; Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea. Food Chem Toxicol 2017,109(Pt 2),970-974","journal-title":"Food Chem Toxicol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/1934578X1501000410","volume":"10","author":"Ho\u0161t\u2019\u00e1lkov\u00e1 A.","year":"2015","unstructured":"Ho\u0161t\u2019\u00e1lkov\u00e1 A.; Opletal L.; Kune\u0161 J.; Nov\u00e1k Z.; Hrabinov\u00e1 M.; Chlebek J.; \u010cegan L.; Cahl\u00edkov\u00e1 L.; Alkaloids from Peumus boldus and their acetylcholinesterase, butyrylcholinesterase and prolyl oligopeptidase inhibition activity. Nat Prod Commun 2015,10(4),577-580","journal-title":"Nat Prod Commun"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"10250","DOI":"10.1021\/acs.jafc.5b04168","volume":"63","author":"Alarc\u00f3n J.","year":"2015","unstructured":"Alarc\u00f3n J.; Cespedes C.L.; Mu\u00f1oz E.; Balbontin C.; Valdes F.; Gutierrez M.; Astudillo L.; Seigler D.S.; Dihydroagarofuranoid sesquiterpenes as acetylcholinesterase inhibitors from Celastraceae plants: Maytenus disticha and Euonymus japonicus. J Agric Food Chem 2015,63(47),10250-10256","journal-title":"J Agric Food Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1177\/1934578X1501000811","volume":"10","author":"Sichaem J.","year":"2015","unstructured":"Sichaem J.; Rojpitikul T.; Sawasdee P.; Lugsannangarm K.; Santi T.P.; Furoquinoline alkaloids from the leaves of Evodia lepta as potential cholinesterase inhibitors and their molecular docking. Nat Prod Commun 2015,10(8),1359-1362","journal-title":"Nat Prod Commun"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1016\/j.bmc.2016.07.043","volume":"24","author":"Wan Othman W.N.N.","year":"2016","unstructured":"Wan Othman W.N.N.; Liew S.Y.; Khaw K.Y.; Murugaiyah V.; Litaudon M.; Awang K.; Cholinesterase inhibitory activity of isoquinoline alkaloids from three Cryptocarya species (Lauraceae). Bioorg Med Chem 2016,24(18),4464-4469","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1016\/j.bmcl.2016.05.046","volume":"26","author":"Abdul Wahab S.M.","year":"2016","unstructured":"Abdul Wahab S.M.; Sivasothy Y.; Liew S.Y.; Litaudon M.; Mohamad J.; Awang K.; Natural cholinesterase inhibitors from Myristica cinnamomea King. Bioorg Med Chem Lett 2016,26(15),3785-3792","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/molecules22101604","volume":"22","author":"Ali M.Y.","year":"2017","unstructured":"Ali M.Y.; Seong S.H.; Reddy M.R.; Seo S.Y.; Choi J.S.; Jung H.A.; Kinetics and molecular docking studies of 6-formyl umbelliferone isolated from Angelica decursiva as an inhibitor of cholinesterase and BACE1. Molecules 2017,22(10),1604","journal-title":"Molecules"},{"key":"ref=71","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9634349","volume":"2018","author":"Kostelnik A.","year":"2018","unstructured":"Kostelnik A.; Pohanka M.; Inhibition of acetylcholinesterase and butyrylcholinesterase by a plant secondary metabolite boldine. BioMed Res Int 2018,2018","journal-title":"BioMed Res Int"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/1934578X1801301011","volume":"13","author":"Sichaem J.","year":"2018","unstructured":"Sichaem J.; Tip-pyang S.; Lugsanangarm K.; Bioactive aporphine alkaloids from the roots of Artabotrys spinosus: cholinesterase inhibitory activity and molecular docking studies. Nat Prod Commun 2018,13(10),1279-1282","journal-title":"Nat Prod Commun"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.20307\/nps.2018.24.4.259","volume":"24","author":"Nugroho A.","year":"2018","unstructured":"Nugroho A.; Choi J.S.; Seong S.H.; Song B.M.; Park K.S.; Park H.J.; Isolation of flavonoid glycosides with cholinesterase inhibition activity and quantification from Stachys japonica. Nat Prod Sci 2018,24(4),259-265","journal-title":"Nat Prod Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/10286020.2017.1319820","volume":"20","author":"Ahmad H.","year":"2018","unstructured":"Ahmad H.; Ahmad S.; Shah S.A.A.; Khan H.U.; Khan F.A.; Ali M.; Latif A.; Shaheen F.; Ahmad M.; Selective dual cholinesterase inhibitors from Aconitum laeve. J Asian Nat Prod Res 2018,20(2),172-181","journal-title":"J Asian Nat Prod Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bioorg.2018.04.008","volume":"78","author":"Ahmad H.","year":"2018","unstructured":"Ahmad H.; Ahmad S.; Ali M.; Latif A.; Shah S.A.A.; Naz H.; Ur Rahman N.; Shaheen F.; Wadood A.; Khan H.U.; Ahmad M.; Norditerpenoid alkaloids of Delphinium denudatum as cholinesterase inhibitors. Bioorg Chem 2018,78,427-435","journal-title":"Bioorg Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14786419.2018.1557176","author":"Karakaya S.","year":"2019","unstructured":"Karakaya S.; Koca M.; Sytar O.; Duman H.; The natural phenolic compounds and their antioxidant and anticholinesterase potential of herb Leiotulus dasyanthus (K. Koch) Pimenov"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.bmcl.2019.03.024","volume":"29","author":"Tu Y.","year":"2019","unstructured":"Tu Y.; Wu C.; Kang Y.; Li Q.; Zhu C.; Li Y.; Bioactivity-guided identification of flavonoids with cholinesterase and \u03b2-amyloid peptide aggregation inhibitory effects from the seeds of Millettia pachycarpa. Bioorg Med Chem Lett 2019,29(10),1194-1198","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.phytol.2019.02.006","volume":"30","author":"\u015alusarczyk S.","year":"2019","unstructured":"\u015alusarczyk S.; Senol Deniz F.S.; Wo\u017aniak D.; Pecio \u0141.; P\u00e9rez-S\u00e1nchez H.; Cer\u00f3n-Carrasco J.P.; Orhan I.E.; Selective in vitro and in silico cholinesterase inhibitory activity of isoflavones and stilbenes from Belamcandae chinensis rhizoma. Phytochem Lett 2019,30,261-272","journal-title":"Phytochem Lett"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.fct.2009.12.019","volume":"48","author":"Herraiz T.","year":"2010","unstructured":"Herraiz T.; Gonz\u00e1lez D.; Anc\u00edn-Azpilicueta C.; Ar\u00e1n V.J.; Guill\u00e9n H.; \u03b2-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol 2010,48(3),839-845","journal-title":"Food Chem Toxicol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.phrs.2009.01.014","volume":"59","author":"Dreiseitel A.","year":"2009","unstructured":"Dreiseitel A.; Korte G.; Schreier P.; Oehme A.; Locher S.; Domani M.; Hajak G.; Sand P.G.; Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B. Pharmacol Res 2009,59(5),306-311","journal-title":"Pharmacol Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jep.2009.01.007","volume":"122","author":"van Diermen D.","year":"2009","unstructured":"van Diermen D.; Marston A.; Bravo J.; Reist M.; Carrupt P.A.; Hostettmann K.; Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol 2009,122(2),397-401","journal-title":"J Ethnopharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.seppur.2008.10.036","volume":"65","author":"Zhou R.","year":"2009","unstructured":"Zhou R.; Wang J.; Li S.; Liu Y.; Supercritical fluid extraction of monoamine oxidase inhibitor from antler velvet. Separ Purif Tech 2009,65(3),275-281","journal-title":"Separ Purif Tech"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.3390\/molecules16086732","volume":"16","author":"Ji H.F.","year":"2011","unstructured":"Ji H.F.; Shen L.; Berberine: a potential multipotent natural product to combat Alzheimer\u2019s disease. Molecules 2011,16(8),6732-6740","journal-title":"Molecules"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4062\/biomolther.2012.20.2.214","volume":"20","author":"Kim J.H.","year":"2012","unstructured":"Kim J.H.; Kim G.H.; Hwang K.H.; Monoamine oxidase and dopamine \u03b2-hydroxylase inhibitors from the fruits of Gardenia jasminoides. Biomol Ther (Seoul) 2012,20(2),214-219","journal-title":"Biomol Ther (Seoul)"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1021\/np100638h","volume":"74","author":"Ho\u0161ek J.","year":"2011","unstructured":"Ho\u0161ek J.; Bartos M.; Chud\u00edk S.; Dall\u2019Acqua S.; Innocenti G.; Kartal M.; Koko\u0161ka L.; Koll\u00e1r P.; Kutil Z.; Landa P.; Marek R.; Z\u00e1valov\u00e1 V.; \u017demli\u010dka M.; \u0160mejkal K.; Natural compound cudraflavone B shows promising anti-inflammatory properties in vitro. J Nat Prod 2011,74(4),614-619","journal-title":"J Nat Prod"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"18936","DOI":"10.3390\/molecules191118936","volume":"19","author":"Chaurasiya N.D.","year":"2014","unstructured":"Chaurasiya N.D.; Ibrahim M.A.; Muhammad I.; Walker L.A.; Tekwani B.L.; Monoamine oxidase inhibitory constituents of propolis: kinetics and mechanism of inhibition of recombinant human MAO-A and MAO-B. Molecules 2014,19(11),18936-18952","journal-title":"Molecules"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1423052","volume":"2016","author":"Zarmouh N.O.","year":"2016","unstructured":"Zarmouh N.O.; Messeha S.S.; Elshami F.M.; Soliman K.F.; Evaluation of the isoflavone genistein as reversible human monoamine oxidase-A and-B inhibitor. Evid Based Complement Alternat Med 2016,2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1016\/j.bmcl.2016.08.044","volume":"26","author":"Lee H.W.","year":"2016","unstructured":"Lee H.W.; Ryu H.W.; Kang M.G.; Park D.; Oh S.R.; Kim H.; Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg Med Chem Lett 2016,26(19),4714-4719","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ijbiomac.2017.06.076","volume":"104","author":"Lee H.W.","year":"2017","unstructured":"Lee H.W.; Ryu H.W.; Baek S.C.; Kang M.G.; Park D.; Han H.Y.; An J.H.; Oh S.R.; Kim H.; Potent inhibitions of monoamine oxidase A and B by acacetin and its 7-O-(6-O-malonylglucoside) derivative from Agastache rugosa. Int. J. Biol. Macromol. 2017,104(Pt A),547-553"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12906-016-1525-y","volume":"17","author":"Zarmouh N.O.","year":"2017","unstructured":"Zarmouh N.O.; Eyunni S.K.; Soliman K.F.; The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor. BMC Complement Altern Med 2017,17(1),34","journal-title":"BMC Complement Altern Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bmcl.2018.01.049","volume":"28","author":"Baek S.C.","year":"2018","unstructured":"Baek S.C.; Lee H.W.; Ryu H.W.; Kang M.G.; Park D.; Kim S.H.; Cho M.L.; Oh S.R.; Kim H.; Selective inhibition of monoamine oxidase A by hispidol. Bioorg Med Chem Lett 2018,28(4),584-588","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejmech.2014.05.048","volume":"82","author":"De Monte C.","year":"2014","unstructured":"De Monte C.; Carradori S.; Chimenti P.; Secci D.; Mannina L.; Alcaro F.; Petzer A.; N\u2019Da C.I.; Gidaro M.C.; Costa G.; Alcaro S.; Petzer J.P.; New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies. Eur J Med Chem 2014,82,164-171","journal-title":"Eur J Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1021\/acs.jafc.5b06043","volume":"64","author":"Gidaro M.C.","year":"2016","unstructured":"Gidaro M.C.; Astorino C.; Petzer A.; Carradori S.; Alcaro F.; Costa G.; Artese A.; Rafele G.; Russo F.M.; Petzer J.P.; Alcaro S.; Kaempferol as selective human MAO-A inhibitor: analytical detection in Calabrian red wines, biological and molecular modeling studies. J Agric Food Chem 2016,64(6),1394-1400","journal-title":"J Agric Food Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"9004","DOI":"10.1021\/acs.jafc.6b03529","volume":"64","author":"Carradori S.","year":"2016","unstructured":"Carradori S.; Gidaro M.C.; Petzer A.; Costa G.; Guglielmi P.; Chimenti P.; Alcaro S.; Petzer J.P.; Inhibition of human monoamine oxidase: biological and molecular modeling studies on selected natural flavonoids. J Agric Food Chem 2016,64(47),9004-9011","journal-title":"J Agric Food Chem"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/178673","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/178673\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/178673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T19:39:55Z","timestamp":1638646795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178673\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":94,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,12,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207323666200127145246","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}